Michael F. Berger
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 154
- Oncology top 0.1%
- Colorectal Cancer Treatments and Studies 30
- Pancreatic and Hepatic Oncology Research 21
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations 51
- Gastric Cancer Management and Outcomes 19
- Pathology and Forensic Medicine top 0.2%
- Genetic factors in colorectal cancer 52
- Molecular Biology top 0.5%
-
- Bladder and Urothelial Cancer Treatments 24
- Cholangiocarcinoma and Gallbladder Cancer Studies 21
- Co-authors
- David B. SolitMarc LadanyiAhmet ZehirNikolaus SchultzHelen WonDavid M. HymanElaine R. MardisMaria E. Arcila
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Michael F. Berger
300 papers receiving 17.1k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Cancer Research 5.1k
- Oncology 7.8k
- Pulmonary and Respiratory Medicine 5.1k
- Pathology and Forensic Medicine 2.7k
- Molecular Biology 7.4k
Countries citing papers authored by Michael F. Berger
This map shows the geographic impact of Michael F. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Berger more than expected).
Fields of papers citing papers by Michael F. Berger
This network shows the impact of papers produced by Michael F. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Berger. The network helps show where Michael F. Berger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael F. Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burdenbreakdown → | 2019 | 289 |
| 2 | 2019 | 14 | |
| 3 | 2018 | 188 | |
| 4 | 2017 | 60 | |
| 5 | 2017 | 317 | |
| 6 | 2017 | 115 | |
| 7 | 2016 | 2 | |
| 8 | Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsetsbreakdown → | 2016 | 325 |
| 9 | 2015 | 111 | |
| 10 | 2015 | 221 | |
| 11 | Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skippingbreakdown → | 2015 | 423 |
| 12 | 2014 | 59 | |
| 13 | 2014 | 219 | |
| 14 | 2014 | 156 | |
| 15 | 2013 | 112 | |
| 16 | Genome Sequencing Identifies a Basis for Everolimus Sensitivitybreakdown → | 2012 | 480 |
| 17 | Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profilingbreakdown → | 2011 | 732 |
| 18 | 2011 | 384 | |
| 19 | Diversity and Complexity in DNA Recognition by Transcription Factorsbreakdown → | 2009 | 761 |
| 20 | 2009 | 163 |
About Michael F. Berger
Michael F. Berger is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 325 papers that have together received 17.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (154 papers), Genetic factors in colorectal cancer (52 papers), Lung Cancer Treatments and Mutations (51 papers), Colorectal Cancer Treatments and Studies (30 papers), Bladder and Urothelial Cancer Treatments (24 papers), Pancreatic and Hepatic Oncology Research (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers) and Gastric Cancer Management and Outcomes (19 papers). The work is most often cited by research in Cancer Research (5.1k citations), Oncology (7.8k citations) and Pulmonary and Respiratory Medicine (5.1k citations). Michael F. Berger has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include David B. Solit, Marc Ladanyi, Ahmet Zehir, Nikolaus Schultz, Helen Won, David M. Hyman, Elaine R. Mardis, Maria E. Arcila, Sasinya N. Scott and José Baselga. Their work appears in journals such as Science, The Lancet and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.